https://www.selleckchem.com/pr....oducts/cyclo-rgdyk.h
BACKGROUND During the ongoing COVID-19 pandemic, contact with the healthcare system for cancer treatment can increase risk of infection and associated mortality. Treatment recommendations must consider this risk for elderly and vulnerable cancer patients. We re-analyzed trials in elderly glioblastoma (GBM) patients, incorporating COVID-19 risk, in order to provide a quantitative framework for comparing different radiation (RT) fractionation schedules on patient outcomes. METHODS We extracted individual patient-level data (IPLD) for
Like
Comment
Share
